Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging

Karen Kurdziel, Esther Mena, Stephen Adler, Yolanda McKinney, Maria Liza Lindenberg, Ismail Baris Turkbey, Karen Wong, Jae-Ho Lee, Chang Paik and Peter Choyke
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1351;
Karen Kurdziel
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Mena
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Adler
2Clinical Monitoring Research Program/Contrator for NCI Molecular Imaging Program Leidos Biomedical Research Inc./Frederick National Laboratory for Cancer Research Frederick (personnel stationed in Bethesda) MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda McKinney
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Liza Lindenberg
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismail Baris Turkbey
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Wong
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jae-Ho Lee
1Radiology and Imaging/Nuclear Medicine Division Clinical Center/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang Paik
1Radiology and Imaging/Nuclear Medicine Division Clinical Center/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Choyke
3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 1351

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Karen Kurdziel3,
  2. Esther Mena3,
  3. Stephen Adler2,
  4. Yolanda McKinney3,
  5. Maria Liza Lindenberg3,
  6. Ismail Baris Turkbey3,
  7. Karen Wong3,
  8. Jae-Ho Lee1,
  9. Chang Paik1 and
  10. Peter Choyke3
  1. 1Radiology and Imaging/Nuclear Medicine Division Clinical Center/National Institutes of Health Bethesda MD United States
  2. 2Clinical Monitoring Research Program/Contrator for NCI Molecular Imaging Program Leidos Biomedical Research Inc./Frederick National Laboratory for Cancer Research Frederick (personnel stationed in Bethesda) MD United States
  3. 3Center for Cancer Research/Molecular Imaging Program National Cancer Institute/National Institutes of Health Bethesda MD United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2023

AbstractFullPdf
May 2016400
Jun 20163800
Jul 20162500
Aug 2016400
Sep 20161200
Oct 2016400
Nov 2016400
Dec 2016500
Jan 2017600
Feb 20171000
Mar 20171300
Apr 2017200
May 2017500
Jun 2017400
Jul 2017500
Sep 2017300
Oct 2017300
Nov 2017500
Dec 2017200
Jan 2018400
Mar 2018600
Apr 2018500
May 20181400
Jul 2018300
Aug 2018400
Sep 20181000
Oct 2018700
Nov 2018100
Dec 2018100
Jan 2019400
Feb 20191000
Mar 2019100
Apr 2019300
May 2019500
Jul 2019100
Sep 2019300
Nov 2019400
Dec 2019200
Jan 2020100
Feb 2020500
Mar 20201500
Apr 2020900
May 20201200
Jun 2020100
Jul 2020200
Aug 2020900
Sep 20202300
Oct 20201500
Nov 20201700
Dec 20201100
Jan 2021500
Feb 20211200
Mar 2021700
Apr 2021800
May 20211100
Jun 2021400
Jul 20212200
Aug 20214000
Sep 20211400
Oct 20211900
Nov 20218300
Dec 20214900
Jan 20227900
Feb 20222300
Mar 20222300
Apr 20222500
May 20223100
Jun 2022400
Jul 2022200
Aug 2022300
Sep 2022300
Oct 2022100
Nov 2022200
Dec 2022400
Jan 2023400
Feb 2023200
Mar 2023200
Apr 2023300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging
Karen Kurdziel, Esther Mena, Stephen Adler, Yolanda McKinney, Maria Liza Lindenberg, Ismail Baris Turkbey, Karen Wong, Jae-Ho Lee, Chang Paik, Peter Choyke
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1351;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First-in-human phase 0 study of 111in-chx-a”-trastuzumab for her2 tumor imaging
Karen Kurdziel, Esther Mena, Stephen Adler, Yolanda McKinney, Maria Liza Lindenberg, Ismail Baris Turkbey, Karen Wong, Jae-Ho Lee, Chang Paik, Peter Choyke
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1351;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Basic Science Posters

  • In Vivo PET/CT neuroimaging of radiolabeled nanocarriers following intranasal drug delivery (INDD): Validation using Ex Vivo PET/CT, gamma counting and autoradiography.
  • 18F-ML10 PET/CT demonstrates therapy-induced apoptosis in murine pancreatic adenocarcinoma
  • New 68Ga AAZTA-bisphosphonates as potential bone imaging agents.
Show more MTA I: Basic Science Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire